Project Details
Description
BENEFIT: Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immuno-suppression Trial
| Status | Finished |
|---|---|
| Effective start/end date | 3/14/06 → 12/1/15 |
Funding
- BRISTOL-MYERS SQUIBB PHARM RES
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.